Enzyre Appoints Dirk Pollet as Chief Executive Officer
Awarded 2M grant and completes seed financing to develop high-precision point-of-care Hemophilia Biochip device
NIJMEGEN, Netherlands, April 30, 2019 -- (Healthcare Sales & Marketing Network) -- Enzyre, which is developing breakthrough ambulant diagno... Diagnostics, Personnel Enzyre , Hemophilia Biochip
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news